Ameritek Ventures, Inc. - Quarter Report: 2019 February (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark one) | |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended February 28, 2019
OR
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _________________to
Commission File Number: 000-54739
|
||
AMERITEK VENTURES
(Exact name of registrant as specified in its charter)
_________________
Nevada | 82-2380777 | |||||
(State or Other Jurisdiction | (I.R.S. Employer | |||||
of Incorporation or Organization) | Identification No.) | |||||
1980 Festival Plaza Drive, Suite 530, Las Vegas, NV | 89135 | ||||
(Address of principal executive offices) | (Zip Code) | ||||
877-571-1776
(Registrant’s telephone number, including area code)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes □ No 🗹
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.
Yes □ No 🗹
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes 🗹 No □
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes □ No 🗹
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. 🗹
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer □ | Accelerated filer | □ | |||||
Non-accelerated filer □ | Smaller Reporting Company | 🗹 | |||||
(Do not check if a smaller reporting company) Emerging growth company □ |
|||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes □ No 🗹
There were 89,744,426 shares of Common Stock issued and outstanding as of May 14, 2019.
Table of Contents
AMERITEK VENTURES
Index to Form 10-Q
For the Quarterly Period Ended February 28, 2019
PART I | Financial Information | 3 |
ITEM 1. | Financial Statements | 3 |
Condensed Balance Sheets | 3 | |
Unaudited Interim Condensed Statements of Operations | 4 | |
Unaudited Interim Condensed Statement of Stockholder’s Deficit | 5 | |
Unaudited Interim Condensed Statements of Cash Flows | 6 | |
Notes to the Unaudited Condensed Interim Financial Statements | 7 | |
ITEM 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 14 |
ITEM 3. | Quantitative and Qualitative Disclosures About Market Risk | 18 |
ITEM 4T. | Controls and Procedures | 18 |
PART II | Other Information | 21 |
ITEM 1. | Legal Proceedings | 21 |
ITEM 1A. | Risk Factors | 21 |
ITEM 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 21 |
ITEM 3 | Defaults Upon Senior Securities | 21 |
ITEM 4 | Submission of Matters to a Vote of Security Holders | 21 |
ITEM 5 | Other Information | 21 |
ITEM 6 | Exhibits | 22 |
SIGNATURES | 23 | |
AMERITEK VENTURES
Unaudited Interim Condensed Balance Sheets
February 28, 2019 | May 31, 2018 | |||||
ASSETS | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ 450 | $ 27,672 | ||||
Cash held in escrow | 12,385 | 12,385 | ||||
Deposits | 521 | 521 | ||||
Total current assets | 13,356 | 40,578 | ||||
Long-term assets: |
||||||
Fiber optic assets | - | - | ||||
Total long-term assets | - | - | ||||
TOTAL ASSETS |
$ 13,356 | $ 40,578 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||
Current liabilities: | ||||||
Accounts payable | $ 163,216 | $ 52,191 | ||||
Convertible notes payable | 431,819 | 503,184 | ||||
Accrued interest | 78,176 | 28,456 | ||||
Due to related party | 77,383 | 52,023 | ||||
Total current liabilities | 750,594 | 635,854 | ||||
Stockholders' deficit: | ||||||
Preferred stock Series B, $0.001 par value, 5,000,000 shares | - | - | ||||
authorized, none issued and outstanding as of | ||||||
2/28/2019 and 5/31/2018, respectively | ||||||
Convertible preferred stock Series A, $0.001 par | 52 | 53 | ||||
value, 5,000,000 shares authorized, 51,627 | ||||||
and 52,927 issued and outstanding as of | ||||||
2/28/2019 and 5/31/2018, respectively | ||||||
Preferred stock Series C, $0.001 par value, 5,000,000 shares | - | - | ||||
authorized, none issued and outstanding as of | ||||||
2/28/2019 and 5/31/2018, respectively | ||||||
Common stock, $0.001 par value, 185,000,000 shares | 61,731 | 33,714 | ||||
authorized, 61,730,599 and 33,714,307 issued and | ||||||
outstanding as of 2/28/2019 and 5/31/2018, | ||||||
Respectively | ||||||
Additional paid-in capital | 597,775 | 448,612 | ||||
Accumulated deficit | (1,396,796) | (1,077,655) | ||||
Total stockholders' deficit | (737,238) | (595,276) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 13,356 | $ 40,578 |
The accompanying notes are an integral part of these financial statements.
AMERITEK VENTURES
Unaudited Interim Condensed Statements of Operations
For the three months ended February 28, 2019 | For the three months ended February 28, 2018 | For the nine months ended February 28, 2019 | For the nine months ended February 28, 2018 | ||||||||
Revenue | $ - | $ - | $ - | $ - | |||||||
Cost of goods sold | - | - | - | - | |||||||
Gross profit | - | - | - | - | |||||||
Expenses: | |||||||||||
General & administrative expenses | 60,103 | 62,432 | 163,607 | 184,798 | |||||||
Total expenses | 60,103 | 62,432 | 163,607 | 184,798 | |||||||
Operating loss | $ (60,103) | $ (62,432) | $ (163,607) | $ (184,798) | |||||||
Other Income (Expenses): | |||||||||||
Interest income (expense) | (13,801) | (2,986) | (155,534) | (6,604) | |||||||
Total other income (expenses) | (13,801) | (2,986) | (155,534) | (6,604) | |||||||
Net loss applicable to | |||||||||||
common shareholders | $ (73,904) | $ (65,418) | $ (319,141) | $ (191,402) | |||||||
Net loss per share - basic and diluted | $ (0.00) | $ (0.00) | $ (0.01) | $ (0.01) | |||||||
Weighted average shares outstanding – basic | 40,678,335 | 27,071,433 | 36,416,583 | 19,334,384 | |||||||
Weighted average shares outstanding - diluted | 46,044,285 | 40,927,433 | 46,044,285 | 32,671,414 | |||||||
The accompanying notes are an integral part of these financial statements.
AMERITEK VENTURES
Statements of Stockholders’ Equity (Deficit)
Series B | Series A Convertible | Additional | Total | |||||||||||||||||||||||||||||||
Preferred Stock | Preferred Stock | Common Stock | Paid-In | Accumulated | Stockholders' | |||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Equity (Deficit) | ||||||||||||||||||||||||||
Balance, May 31, 2018 | - | - |
52,927 |
153 |
33,714,307 |
733,714 |
448,612 |
(1.077,655) | (595,276) | |||||||||||||||||||||||||
Conversion of Accrued Interest and Convertible Debt for Common Stock | - | - |
- |
- |
499,838 |
500 |
39,137 |
- | 39,637 | |||||||||||||||||||||||||
Conversion of Accrued Interest and Convertible Debt for Common Stock |
- | - |
- |
- |
655,738 |
656 |
7,344 |
- | 8,000 | |||||||||||||||||||||||||
Conversion of Accrued Interest and Convertible Debt for Common Stock |
- | - |
- |
- |
26,730,716 |
26,731 |
102,811 |
- | 129,542 | |||||||||||||||||||||||||
Conversion of Series A Preferred Stock to Common Stock |
- | - |
(1,300) |
(1) |
130,000 |
130 |
(129) |
- | - | |||||||||||||||||||||||||
Net loss |
- | - | - | - | - | - | - | (319,141) | (319,141) | |||||||||||||||||||||||||
Balance, February 28, 2019 |
- | $ - |
51,627 |
$52 |
61,730,599 |
$61,731 |
$ 597,775 |
$(1,396,796) | $ (737,238) | |||||||||||||||||||||||||
The accompanying notes are an integral part of these financial statements.
AMERITEK VENTURES
Unaudited Interim Condensed Statements of Cash Flows
For the nine months ended February 28, 2019 | For the nine months ended February 28, 2018 | ||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||
Net loss | $ (319,141) | $ (191,402) | |||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||
Changes in operating assets and liabilities: | |||||
Deposits | - | (521) | |||
Accounts payable | 111,025 | 3,711 | |||
Accrued expenses | 155,534 | (3,396) | |||
Net cash used in operating activities | (52,582) | (191,608) | |||
CASH FLOWS FROM INVESTING ACTIVITIES |
|||||
Shareholder and officer advances | $ 25,360 | 77,516 | |||
Cash paid for purchase of fiber optic assets | - | (100,000) | |||
Net cash provided by (used in)investing activities | 25,360 | (22,484) | |||
CASH FLOWS FROM FINANCING ACTIVITIES |
|||||
Proceeds for issuance of common stock | $ - | $ 100,000 | |||
Proceeds from convertible debt | - | 129,000 | |||
Net cash provided by financing activities | - | 229,000 | |||
NET INCREASE (DECREASE) IN CASH |
(27,222) | 14,908 | |||
CASH - BEGINNING OF THE PERIOD | 40,057 | - | |||
CASH - END OF THE PERIOD | $ 12,835 | $ 14,908 | |||
Supplemental Cash Disclosures | |||||
Accrued interest converted to common stock |
$ 20,314 | $ - | |||
Note payable converted to common stock | $ 156,865 | $ - |
The accompanying notes are an integral part of these financial statements.
AMERITEK VENTURES
Notes to the Unaudited Condensed Interim Financial Statements
February 28, 2019
NOTE 1 - CONDENSED INTERIM FINANCIAL STATEMENTS
The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at February 28, 2019 and for all periods presented have been made.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's May 31, 2018 audited financial statements. The results of operations for the period ended February 28, 2019 are not necessarily indicative of the operating results for the full year.
Basis of Presentation
In the opinion of management, the accompanying interim balance sheets and related interim statements of income and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Preparing financial statements requires management to make estimates and assumptions the affect the reported amounts of assets, liabilities, revenue and expenses. Actual results and outcomes may differ from management's estimates and assumptions.
NOTE 2 - GOING CONCERN
These condensed interim financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. As of February 28, 2019, the Company has accumulated operating losses of $1,396,796 since inception. The Company's ability to continue as a going concern is contingent upon the successful completion of additional financing arrangements and its ability to achieve and maintain profitable operations.
Management plans to raise equity capital to finance the operating and capital requirements of the Company. Amounts raised will be used to further development of the Company's products, to provide financing for marketing and promotion, to secure additional property and equipment, and for other working capital purposes. While the Company is putting forth its best efforts to achieve the above plans, there is no assurance that any such activity will generate funds that will be available for operations.
These conditions raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments that might arise from this uncertainty.
NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Recent Accounting Pronouncements
The Company's management has evaluated all the recently issued accounting pronouncements through the filing date of these financial statements and does not believe that any of these pronouncements will have a material impact on the Company's financial position and results of operations.
NOTE 4 - STOCKHOLDERS' EQUITY AND CONTRIBUTED CAPITAL
Series B Preferred Stock
The Company is authorized to issue 5,000,000 shares of $0.001 par value Series B Preferred Stock. Series B Preferred Stock has liquidation and first position ownership rights on any assets owned by the Company. The Series B Preferred Stock has no voting rights and are not entitled to receive dividends. The holders of Series B Preferred Stock shall be entitled to interest payments on monies paid or loaned to the corporation for their Series B Preferred Shares and a first position in a security interest on any assets of the Company upon default of a loan to the Company, liquidation or dissolution of the Company. Further, the Company may call these shares at any time provided the holders of the Series B Preferred Stock are paid the amount of monies they paid for their Series B Preferred Stock along with any interest due. Upon the payment of principal and interest to the Series B Preferred Stock shareholders, the shares must be returned to the Company.
As of February 28, 2019, there was no Series B Preferred Stock outstanding.
Series A Preferred Stock
The Company is authorized to issue 5,000,000 shares of $0.001 par value Series A Preferred Stock. Series A Preferred Stock have no liquidation rights. Series A Preferred Stock shall not be entitled to receive any dividends nor are they entitled to any voting rights with respect to the Series A Preferred Stock. At any time and from time-to-time after the issuance of the Series A Preferred Stock, any holder may convert any or all of the shares of Series A Preferred Stock held by such holder at the ratio of one hundred (100) shares of Common Stock for every one (1) share of Series A Preferred Stock. However, the beneficial owner of such Series A Preferred Stock cannot convert their Series A Preferred stock where they will beneficially own in excess of 4.9% of the shares of the Common Stock.
During the nine-month period ended February 28, 2019, there were no issuances of Series A Preferred Stock.
As of February 28, 2019, there were 51,627 shares of Series A Preferred Stock issued and outstanding.
Series C Preferred Stock
The Company is authorized to issue 5,000,000 shares of $0.001 par value Series C Preferred Stock, of which no shares are issued and outstanding as of February 28, 2019. On March 25, 2019, the Board approved the designation of the Company’s Five Million (5,000,000) Series C Preferred Shares. The total number of authorized shares constituting this series of preferred stock of the Company may be increased or decreased at any time, from time to time, in accordance with applicable law up to the maximum number of shares of preferred stock authorized under the Articles, less all shares at the time authorized of any other series of preferred stock of the Company; provided, however, that no decrease shall reduce the number of shares of this series to a number less than that of the then-outstanding shares of Series C Voting Preferred Stock. The stated par value of the Series C Voting Preferred Stock shall be $0.001 per share. The holders of shares of Series C Voting Preferred Stock shall not be entitled to receive any dividends. The holders of shares of Series C Voting Preferred Stock shall not have any liquidation rights. The holders of Series C Voting Preferred Stock shall be entitled to (a) notice of any meeting of the shareholders of the Company; and (b) have the power to vote each share at any shareholder meeting, where each share of Series C Voting Preferred Stock carries the weight of five hundred (500) votes for each share of common stock. The holders of the Series C Voting Preferred Stock shall be entitled to transfer their ownership and rights of the Series C Voting Preferred Stock at any time, in a private transaction.
Common Stock
The Company is authorized to issue 185,000,000 shares of its $0.001 par value common stock, of which 61,730,599 shares are issued and outstanding as of February 28, 2019.
On July 5, 2018, one of the holders of the Company’s convertible promissory notes converted $28,300 of principal and $11,337 of accrued interest into 499,838 shares of the Company’s common stock.
On September 10, 2018, one of the holders of the Company’s Series A preferred stock converted 1,300 preferred shares to 130,000 shares of common stock.
On October 12, 2018, one of the holders of the Company’s convertible promissory notes converted $8,000 of principal into 655,738 shares of the Company’s common stock.
On December 4, 2018, one of the holders of the Company’s convertible promissory notes converted $13,000 of principal and $740.82 of accrued interest into 964,268 shares of the Company’s common stock.
On January 14, 2019, one of the holders of the Company’s convertible promissory notes converted $7,000 of principal and $7,099 of accrued interest into 1,712,085 shares of the Company’s common stock.
On January 14, 2019, one of the holders of the Company’s convertible promissory notes converted $12,000 of principal into 1,705,455 shares of the Company’s common stock.
On January 31, 2019, one of the holders of the Company’s convertible promissory notes converted $9,625 of principal into 1,964,286 shares of the Company’s common stock.
On February 4, 2019, one of the holders of the Company’s convertible promissory notes converted $5,850 of principal and $579 of accrued interest into 2,014,171 shares of the Company’s common stock.
On February 8, 2019, one of the holders of the Company’s convertible promissory notes converted $8,445 of principal into 1,963,953 shares of the Company’s common stock.
On February 11, 2019, one of the holders of the Company’s convertible promissory notes converted $9,720 of principal into 2,260,465 shares of the Company’s common stock.
On February 19, 2019, one of the holders of the Company’s convertible promissory notes converted $9,715 of principal into 2,259,302 shares of the Company’s common stock.
On February 19, 2019, one of the holders of the Company’s convertible promissory notes converted $6,900 of principal and $510 of accrued interest into 2,321,428 shares of the Company’s common stock.
On February 20, 2019, one of the holders of the Company’s convertible promissory notes converted $9,830 of principal into 2,286,047 shares of the Company’s common stock.
On February 21, 2019, one of the holders of the Company’s convertible promissory notes converted $8,600 of principal and $47 of accrued interest into 2,709,145 shares of the Company’s common stock.
On February 25, 2019, one of the holders of the Company’s convertible promissory notes converted $9,825 of principal into 2,284,884 shares of the Company’s common stock.
On February 27, 2019, one of the holders of the Company’s convertible promissory notes converted $10,055 of principal into 2,285,227 shares of the Company’s common stock.
NOTE 5 - RELATED PARTY TRANSACTIONS
Advances
As needed, the Company has received numerous advances from the Company’s current majority shareholder, Chief Executive Officer, Principal Executive Officer as well as previous advances from two of the Company’s former Director and Principal Executive officers. The advances as of May 31, 2018 was $52,023. The total balance owed to related parties at February 28, 2019 was $77,383. These advances are payable on demand and bears no interest.
NOTE 6 - NOTE PAYABLE
On July 31, 2017, the Company entered into a convertible note agreement in which the Company received $65,000 of proceeds and the Company is required to make a balloon payment of principal and accrued interest of $70,200 on the maturity date of April 31, 2018. This note accumulates interest at a rate of 8% from the original issue date through the maturity date. At any time while there is an outstanding balance, the note may be converted at a conversion price for the principal and interest in connection with voluntary conversions by the holder shall be 75% multiplied by the market price, representing a discount rate of 25%. The note also provides for warrants of up to 208,000 shares of common stock which may be exercised any time from the issuance date of July 31, 2017 (initial exercise date) until July 31, 2022 (termination date). The exercise price of this warrant is $1.35. Further, if at any time after the initial exercise date, there is no effective registration statement registering the warrant shares, or no current prospectus available for the resale of the warrant shares by the holder, then the warrant may be exercised at the holder’s election, in whole or in part, at such times by means of a cashless exercise in which the holder shall be entitled to receive a number of warrant shares equal to the quotient obtained by dividing [(A-B)(X)] by (A), where (A) equals the VWAP on the trading day immediately preceding the date on which the holder elects to exercise the warrant; (B) equals the exercise price of the warrant; and (X) equals the number of warrant shares that would be issuable upon exercise of the warrant if such exercise were by means of a cash exercise rather than a cashless exercise. Regardless, on the termination date if there is no effective Registration Statement registering the warrant shares, or no current prospectus available for the resale of the warrant shares by the holder, then the warrant shall be automatically exercised via cashless exercise. Failure of the Company to issue shares in a timely manner will result in a late issuance penalty of $10 per trading day, increasing to $20 per trading day after the fifth trading day, for each $1,000 of exercise price of the warrant shares.
In the event of default, the outstanding amount due on the note will be adjusted to the mandatory default amount which is the sum of (a) the greater of (i) the outstanding principal amount of this Note divided by the Conversion Price on the date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note plus (b) all other amounts, costs, expenses and liquidated damages due in respect of this note. Also as a result of default, interest on this note shall accrue at an interest rate equal to the lesser of 24% per annum or the maximum rate permitted under applicable law.
During the year ended May 31, 2018, the Company was in default with the convertible note agreement and certain adjustments have been recorded by the Company to factor in the default remedies. The adjustment included an increase in interest to 24% per annum as well as an increase in the total principal amount due by $14,040.
On July 5, 2018, the convertible note agreement holder converted $28,300 of principal and $11,337 of accrued interest into 499,838 shares of the Company’s common stock.
On January 14, 2019, the convertible note agreement holder converted $7,000 of principal and $7,099 of accrued interest into 1,712,085 shares of the Company’s common stock.
On February 4, 2019, the convertible note agreement holder converted $5,850 of principal and $579 of accrued interest into 2,014,171 shares of the Company’s common stock.
On February 19, 2019, the convertible note agreement holder converted $6,900 of principal and $510 of accrued interest into 2,321,428 shares of the Company’s common stock.
On February 21, 2019, the convertible note agreement holder converted $8,600 of principal and $47 of accrued interest into 2,709,145 shares of the Company’s common stock.
The total amount of principal due under the convertible promissory note at February 28, 2019 and May 31, 2018 was $27,590 and 84,240, respectively.
On August 25, 2017, the Company entered into a convertible note agreement in which the Company received $64,000 of proceeds and the Company is required to make a balloon payment of principal and accrued interest of $69,120 on the maturity date of August 25, 2018. This note accumulates interest at a rate of 8% from the original issue date through the maturity date. At any time while there is an outstanding balance, the note may be converted at a conversion price for the principal and interest in connection with voluntary conversions by the holder shall be 75% multiplied by the market price, representing a discount rate of 25%. The note also provides for warrants of up to 204,800 shares of common stock which may be exercised any time from the issuance date of August 25, 2017 (initial exercise date) until August 25, 2022 (termination date). The exercise price of this warrant is $1.35. Further, if at any time after the initial exercise date, there is no effective registration statement registering the warrant shares, or no current prospectus available for the resale of the warrant shares by the holder, then the warrant may be exercised at the holder’s election, in whole or in part, at such times by means of a cashless exercise in which the holder shall be entitled to receive a number of warrant shares equal to the quotient obtained by dividing [(A-B)(X)] by (A), where (A) equals the VWAP on the trading day immediately preceding the date on which the holder elects to exercise the warrant; (B) equals the exercise price of the warrant; and (X) equals the number of warrant shares that would be issuable upon exercise of the warrant if such exercise were by means of a cash exercise rather than a cashless exercise. Regardless, on the termination date if there is no effective Registration Statement registering the warrant shares, or no current prospectus available for the resale of the warrant shares by the holder, then the warrant shall be automatically exercised via cashless exercise. Failure of the Company to issue shares in a timely manner will result in a late issuance penalty of $10 per trading day, increasing to $20 per trading day after the fifth trading day, for each $1,000 of exercise price of the warrant shares.
In the event of default, the outstanding amount due on the note will be adjusted to the mandatory default amount which is the sum of (a) the greater of (i) the outstanding principal amount of this Note divided by the Conversion Price on the date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note plus (b) all other amounts, costs, expenses and liquidated damages due in respect of this note. Also as a result of default, interest on this note shall accrue at an interest rate equal to the lesser of 24% per annum or the maximum rate permitted under applicable law.
During the year ended May 31, 2018, the Company was in default with the convertible note agreement and certain adjustments have been recorded by the Company to factor in the default remedies. The adjustment included an increase in interest to 24% per annum as well as an increase in the total principal amount due by $13,824.
The total amount of principal due under the convertible promissory note at February 28, 2019 and May 31, 2018 was $82,944, respectively.
On March 12, 2018 the Company entered into a convertible note agreement in which the Company received $103,000 of proceeds and the Company is required to make a balloon payment of principal and accrued interest of $115,360 on the maturity date of March 12, 2019. This note accumulates interest at a rate of 12% from the original issue date through the maturity date or in the event of default the note will accumulate interest at a rate of 22%. From time to time, and at any time during the period beginning on the date which is one hundred eighty (180) days following the date of the Note and ending on the later of: (i) the Maturity Date and (ii) the date of the payment of the Default Amount, each in respect of the remaining outstanding principal amount of this Note to convert all or any part of the outstanding and unpaid principal amount of this Note into fully paid and non-assessable shares of Common Stock, as such common stock exists on the issue Date, or any shares of capital stock or other securities of the borrower into which such Common stock shall hereafter be changed or reclassified at the conversion price determined as provided. The Conversion Price shall equal the Variable Conversion Price (subject to equitable adjustments by the Borrower relating to the Borrower’s securities). The Variable Conversion Price shall mean 61% multiplied by the Market Price, representing a 39% discount rate. Market Price means the lowest Trading Price for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. Trading Price means, for any security as of any date, the closing bid price on the OTCQB, OTCQX, Pink Sheets electronic quotation system or applicable trading market (the “OTC”). The Borrower is required at all times to have authorized and reserved eight times the number of shares that would be issuable upon full conversion of the Note in effect from time to time, initially 2,214,458 (the “Reserved Amount”).
On October 12, 2018, the convertible note agreement holder converted $8,000 of principal into 655,738 shares of the Company’s common stock.
During the quarter ended November 30, 2018, the Company was in default with the convertible note agreement and certain adjustments have been recorded by the Company to factor in the default remedies. The adjustment included an increase in interest to 22% per annum as well as an increase in the total principal amount due by $51,500.
On January 14, 2019, the convertible note agreement holder converted $12,000 of principal into 1,705,455 shares of the Company’s common stock.
On January 31, 2019, the convertible note agreement holder converted $9,625 of principal into 1,964,286 shares of the Company’s common stock.
On February 8, 2019, the convertible note agreement holder converted $8,445 of principal into 1,963,953 shares of the Company’s common stock.
On February 11, 2019, the convertible note agreement holder converted $9,720 of principal into 2,260,465 shares of the Company’s common stock.
On February 19, 2019, the convertible note agreement holder converted $9,715 of principal into 2,259,302 shares of the Company’s common stock.
On February 20, 2019, the convertible note agreement holder converted $9,830 of principal into 2,286,047 shares of the Company’s common stock.
On February 25, 2019, the convertible note agreement holder converted $9,825 of principal into 2,284,884 shares of the Company’s common stock.
On February 27, 2019, the convertible note agreement holder converted $10,055 of principal into 2,285,227 shares of the Company’s common stock.
The total amount of principal due under the convertible promissory note at February 28, 2019 and May 31, 2018 was $67,285 and $103,000, respectively.
On April 27, 2018 the Company entered into a convertible note agreement in which the Company received $68,000 of proceeds and the Company is required to make a balloon payment of principal and accrued interest of $76,160 on the maturity date of April 27, 2019. This note accumulates interest at a rate of 12% from the original issue date through the maturity date or in the event of default the note will accumulate interest at a rate of 22%. From time to time, and at any time during the period beginning on the date which is one hundred eighty (180) days following the date of the Note and ending on the later of: (i) the Maturity Date and (ii) the date of the payment of the Default Amount, each in respect of the remaining outstanding principal amount of this Note to convert all or any part of the outstanding and unpaid principal amount of this Note into fully paid and non-assessable shares of Common Stock, as such common stock exists on the issue Date, or any shares of capital stock or other securities of the borrower into which such Common stock shall hereafter be changed or reclassified at the conversion price determined as provided. The Conversion Price shall equal the Variable Conversion Price (subject to equitable adjustments by the Borrower relating to the Borrower’s securities). The Variable Conversion Price shall mean 61% multiplied by the Market Price, representing a 39% discount rate.
Market Price means the lowest Trading Price for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. Trading Price means, for any security as of any date, the closing bid price on the OTCQB, OTCQX, Pink Sheets electronic quotation system or applicable trading market (the “OTC”). The Borrower is required at all times to have authorized and reserved eight times the number of shares that would be issuable upon full conversion of the Note in effect from time to time, initially 1,350,820 (the “Reserved Amount”).
During the quarter ended February 28, 2019, the Company was in default with the convertible note agreement. The adjustment included an increase in interest to 22% per annum as well as an increase in the total principal amount due by $34,000. The total amount of principal due under the convertible promissory note at February 28, 2019 and May 31, 2018 was $102,000 and $68,000, respectively.
On May 140, 2018 the Company entered into a convertible note agreement in which the Company received $160,000 of proceeds and the Company is required to make a balloon payment of principal and accrued interest of $181,500 on the maturity date of May 140, 2019. This note accumulates interest at a rate of 10% from the original issue date through the maturity date. The Holder of this Note is entitled, at its option, at any time after 6 months and full cash payment, to convert all or any amount of the principal face amount of this Note then outstanding into shares of the company’s common stock at a Conversion Price for each share of Common Stock equal to 57% of the lowest trading price of the Common Stock as reported on the National Quotations Bureau OTC market exchange which the Company’s shares are traded or any exchange upon which the Common Stock may be traded in the future, for the 20 prior trading days including the day upon which a Notice of Conversion is received by the Company. The Company shall reserve 1,536,000 shares of its Common Stock for conversions under this Note, (the “Share Reserve”). This note was secured by the pledge of the $165,000 10% convertible promissory note issued to the Company by the lender. The Company may exchange this collateral for other collateral with an appraised value of at least $160,000, by providing 3 days prior written notice to the lender.
On December 4, 2018, one of the holders of the Company’s convertible promissory notes converted $13,000 of principal and $740 of accrued interest into 964,268 shares of the Company’s common stock.
The total amount of principal due under the convertible promissory note at February 28, 2019 and May 31, 2018 was $152,000 and $165,000, respectively.
NOTE 8 – INCOME TAXES
The Company accounts for income taxes under FASB Accounting Standard Codification ASC 740 "Income Taxes". ASC 740 provides that deferred tax assets and liabilities are recorded based on the differences between the tax basis of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized.
As of February 28, 2019, the Company did not have any eligible net operating loss carry forwards as the Company has not filed the appropriate federal and state income tax returns so any accumulated net operating losses could be subject to the respective tax agency disallowance. Any actual net operating losses would be limited by a valuation allowance, as their realization, as determined by management, is determined to be not likely to occur and accordingly, the Company would have recorded a valuation allowance for the deferred tax asset relating to the tax potential net operating loss carry-forwards. Additionally, actual net operating losses carry-forwards and the related deferred tax assets would also be limited due to the various changes in control that has occurred during prior reporting periods.
NOTE 9 - SUBSEQUENT EVENTS
On March 4, 2019, one of the holders of the Company’s convertible promissory notes converted $7,775 of principal into 2,286,765 shares of the Company’s common stock.
On March 6, 2019, one of the holders of the Company’s convertible promissory notes converted $5,940 of principal into 2,284,615 shares of the Company’s common stock.
On March 8, 2019, one of the holders of the Company’s convertible promissory notes converted $5,945 of principal into 2,286,538 shares of the Company’s common stock.
On March 11, 2019, one of the holders of the Company’s convertible promissory notes converted $5,485 of principal into 2,285,417 shares of the Company’s common stock.
On March 12, 2019, one of the holders of the Company’s convertible promissory notes converted $3,000 of principal into 1,250,000 shares of the Company’s common stock.
On March 12, 2019, one of the holders of the Company’s warrants had issued 3,230,769 shares of the Company’s common stock.
On March 15, 2019, one of the holders of the Company’s convertible promissory notes converted $8,480 of principal into 3,533,333 shares of the Company’s common stock.
On March 18, 2019, one of the holders of the Company’s convertible promissory notes converted $5,788 of principal into 2,630,781 shares of the Company’s common stock.
On March 12, 2019, one of the holders of the Company’s warrants had issued 3,995,122 shares of the Company’s common stock.
On March 26, 2019, one of the holders of the Company’s convertible promissory notes converted $7,600 of principal and $599 of accrued interest into 4,230,477 shares of the Company’s common stock.
On March 25, 2019, the Board approved the designation of the Company’s Five Million (5,000,000) Series C Preferred Shares. The total number of authorized shares constituting this series of preferred stock of the Company may be increased or decreased at any time, from time to time, in accordance with applicable law up to the maximum number of shares of preferred stock authorized under the Articles, less all shares at the time authorized of any other series of preferred stock of the Company; provided, however, that no decrease shall reduce the number of shares of this series to a number less than that of the then-outstanding shares of Series C Voting Preferred Stock. The stated par value of the Series C Voting Preferred Stock shall be $0.001 per share. The holders of shares of Series C Voting Preferred Stock shall not be entitled to receive any dividends. The holders of shares of Series C Voting Preferred Stock shall not have any liquidation rights. The holders of Series C Voting Preferred Stock shall be entitled to (a) notice of any meeting of the shareholders of the Company; and (b) have the power to vote each share at any shareholder meeting, where each share of Series C Voting Preferred Stock carries the weight of five hundred (500) votes for each share of common stock. The holders of the Series C Voting Preferred Stock shall be entitled to transfer their ownership and rights of the Series C Voting Preferred Stock at any time, in a private transaction.
On March 26, 2019, Ameritek Ventures (“ATVK or “the Company”) sold 1,000,000 shares of its Series C Voting Preferred Stock to Chaka Renee Mann, in exchange for $4,000. These newly issued shares will not be registered under the Securities Act of 1933, as amended (the "Act") and are to be issued in the reliance upon the exemption from registration provided by section 4(2) of the Act, Regulation 506, on the basis that the transaction does not involve a public offering.
The Company has evaluated subsequent events through the date the financial statements were available to be issued.
Item 2. - Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Information
This Quarterly Report on Form 10-Q contains forward-looking statements. When used in this Quarterly Report on Form 10-Q, the words "anticipate," "believe," "estimate," "will," "plan," "seeks," "intend," and "expect" and similar expressions identify forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in any forward-looking statements are reasonable, these plans, intentions, or expectations may not be achieved. Our actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied, by the forward-looking statements contained in this Quarterly Report on Form 10-Q. Important factors that could cause actual results to differ materially from our forward-looking statements are set forth in this Quarterly Report on Form 10-Q All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth in this Quarterly Report on Form 10-Q. Except as required by federal securities laws, we are under no obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.
Critical Accounting Policies
There have been no material changes to our critical accounting policies and estimates from the information provided in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations", included in our Annual report on Form 10-K for the fiscal year ended May 31, 2018.
Business of the Issuer
We were incorporated on December 27, 2010 as ATVROCKN, a Nevada corporation. On June 20, 2017, our corporate name was changed to Ameritek Ventures. We consider ourselves to be a smaller reporting company under applicable federal securities laws and will be subject to reduced public company reporting requirements. Under our original business plan, it was our intention to market a "housing molding" product to place audio equipment and lighting on 4-wheel drive vehicles such as All Terrain Vehicles (“ATV”) and Utility Terrain Vehicles (“UTV”). We did not manufacture any units as we utilized the services of a contract manufacturer to make the unit for us. We had no material agreement with our contract manufacturer other than we paid them to produce product for us based on our needs. As we were undercapitalized, we were unable to produce the required housing molding(s) we believe would best sell in the ATV/UTV aftermarket.
In August 2017, the Company completed its move into a new production and design facility in Roanoke, Virginia. On August 30, 2017, the Company acquired fiber optic assets from its largest shareholder and director. In this facility the Company will be finalizing design work for its first 5 million km/year VAD/OVD (Vapor Axial Deposition/Outside Vapor Deposition) optical fiber preform production line, slated for assembly, testing and production in 2020. This process makes optical fiber preforms that are the mainstay for fiber optic cable that is used in the telecommunications industry to transmit large amounts of data to and from communication towers for the internet, cable television and telephone industries. This new VAD/OVD production line represents the first phase of a planned 20 million km/year preform manufacturing facility. Ameritek Ventures’ brand-new design and technology hub will help execute the Company's sustained growth and emergence strategy as a provider of high-quality optical fiber preforms for the rapidly expanding Fiber Optic Cable worldwide market that in the past has been dominated by firms like Corning Incorporated, Shin-Etsu Chemical Co. Ltd., Prysmian SpA, Jiangsu Fasten Co. Ltd and Fujikura Ltd.
Implications of Being an “Smaller Reporting Company”
Certain reduced reporting requirements and exemptions are available to us due to the fact that we qualify as a “smaller reporting company” under SEC rules. For instance, smaller reporting companies are not required to obtain an auditor attestation report regarding management’s assessment of internal control over financial reporting; are not required to provide a compensation discussion and analysis; are not required to a pay-for-performance graph or CEO pay ratio disclosure; and may present only two years of audited financial statements and related MD&A disclosure.
Investors should be aware that we will be subject to the "Penny Stock" rules adopted by the Securities and Exchange Commission, which regulate broker-dealer practices in connection with transactions in Penny Stocks. These regulations may have the effect of reducing the level of trading activity, if any, in the secondary market for our stock, and investors in our common stock may find it difficult to sell their shares.
Market Size
The current market value of the optical fiber industry is $3 billion US dollars and is projected to grow to over $5 billion US dollars by 2021. An increase of almost 10,000 tons of perform is projected in the next five years, which is equivalent to more than 300 million kilometers per year of performs.
Competition
We will be involved in intense competition with other business entities, many of which will have a competitive edge over us by virtue of their more substantial financial resources and prior experience in business. Some examples include firms like Corning Incorporated, Shin-Etsu Chemical Co. Ltd., Prysmian SpA, Jiangsu Fasten Co. Ltd and Fujikura Ltd. We also face numerous other smaller companies at the same stage of development as we are.
Patents, Trademarks Licenses and Other Intellectual Property
On August 30, 2017, the Company acquired fiber optic assets, in the form of intellectual property from its largest shareholder and director. These assets consist of proven designs that in the future may be used to fabricate and assemble machines incorporating knowledge from the manufacture of completed equipment for a new PCVD (Plasma Chemical Vapor Deposition) technology that is used in the manufacturing of specialty optical fiber preforms, which is the basis for specialized optical fiber production to satisfy a variety of fiber optic cable applications. Prior to building any PCVD machines, the Company will be using this intellectual property in finalizing design work for its first 5 million km/year VAD/OVD (Vapor Axial Deposition/Outside Vapor Deposition) optical fiber preform production line, slated for assembly, testing and production in 2020. This process makes optical fiber preforms that are the mainstay for fiber optic cable that is used in the telecommunications industry to transmit large amounts of data to and from communication towers for the Internet, cable television and telephone industries. This new VAD/OVD production line represents the first phase of a planned 20 million km/year preform manufacturing facility. Ameritek Ventures’ brand-new design and technology hub will help execute the Company's sustained growth and emergence strategy as a provider of high-quality optical fiber preforms for the rapidly expanding Fiber Optic Cable worldwide market.
Properties
The Company's corporate headquarters are located at: 1980 Festival Plaza Drive, Suite 530, Las Vegas, Nevada 89135. The Company does not own any real property, however did rent warehouse space for its production facility in Roanoke, Virginia at a cost of $2,812.50 per month. This lease had a one year term, however, this lease is currently in default and the Company exited this location on 3/1/19.
RESULTS OF OPERATIONS
For the three and nine month periods ending February 28, 2019, the Company recognized no revenues.
For the three month period ending February 28, 2019, the Company incurred total operating losses of $60,103. This compares to the same period ending February 28, 2018 where the Company incurred total operating losses of $62,432. The net loss applicable to common shareholders was $73,,904 for the three months ending February 28, 2019 or $(0.00) per common share basic and diluted for the period ending as compared to a net loss applicable to common shareholders of $65,418 or $(0.00) per common share for the same period last year.
For the nine month period ending February 28, 2019, the Company incurred total operating losses of $163,607. This compares to the same period ending February 28, 2018 where the Company incurred total operating losses of $184,798. The net loss applicable to common shareholders was $319,141 for the nine months ending February 28, 2019 or $(0.01) per common share basic and diluted for the period ending as compared to a net loss applicable to common shareholders of $191,402 or $(0.01) per common share for the same period last year.
Going Concern
Our ability to continue as a going concern is contingent upon the successful completion of additional financing arrangements and our ability to achieve and maintain profitable operations.
Therefore, management plans to raise equity capital to finance the operating and capital requirements of the Company. While the Company is devoting its best efforts to achieve the above plans, there is no assurance that any such activity will generate funds that will be available for operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern.
Summary of product research and development that we will perform for the term of our plan of operation.
We have no plans to perform any product research and development at this time.
Expected purchase or sale of plant and significant equipment
Management is currently identifying equipment needed in order to begin manufacturing.
Significant changes in the number of employees
We currently have a total of five employees, two of which serve as our officers, one employee who serves as the Company controller and two employees who work in the engineering and design facility. We are dependent upon our officers for our future business development. As our operations expand we anticipate the need to hire additional employees, consultants and professionals; however, the exact number is not quantifiable at this time.
Liquidity and Capital Resources
As of February 28, 2019, Ameritek Ventures had $450 in cash and cash equivalents, $12,385 of cash held in escrow and deposits of $521 for total current assets of $13,356. As of February 28, 2019, Ameritek Ventures had total current liabilities of $750,594.
The Company has limited financial resources available, which has had an adverse impact on the Company's liquidity, activities and operations. These limitations have adversely affected the Company's ability to obtain certain projects and pursue additional business. Without realization of additional capital, it would be unlikely for the Company to continue as a going concern. Management intends to raise additional debt or equity financing to fund ongoing operations and necessary working capital. However, there is no assurance that such financing plans will be successful or be obtained in amounts sufficient to meet the Company’s needs.
Notwithstanding, Ameritek Ventures anticipates generating losses and therefore may be unable to continue operations in the future. Ameritek Ventures anticipates it will require additional capital in order to develop its business. Ameritek Ventures may use a combination of equity and/or debt instruments to funds its growth strategy or enter into a strategic arrangement with a third party.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.
Critical Accounting Policies and Estimates
Revenue Recognition: The Company recognizes revenue related to product sales when (i) persuasive evidence of the arrangement exists, (ii) shipment has occurred, (iii) the fee is fixed or determinable, and (iv) collectability is reasonably assured.
Recent Pronouncements
The Company's management has evaluated all the recently issued accounting pronouncements through the filing date of these financial statements and does not believe that any of these pronouncements will have a material impact on the Company's financial position and results of operations.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
Not applicable.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our disclosure controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules and forms adopted by the SEC, and that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Accounting Officer, to allow timely decisions regarding required disclosures.
Management, with the participation of the Chief Executive Officer, Chief Accounting Officer, and Company Controller, who are all members of our Board of Directors, have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Form 10-Q. Based on such evaluation, the Board of Directors concluded that, as of February 28, 2019, our disclosure controls and procedures were not effective. Our disclosure controls and procedures were not effective because of the "material weaknesses" described below under "Management's annual report on internal control over financial reporting," which are in the process of being remediated as described below under "Management Plan to Remediate Material Weaknesses."
Management's Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in rules promulgated under the Exchange Act, is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Accounting Officer and affected by our Board of Directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Internal control over financial reporting includes those policies and procedures that:
∙ pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
∙ provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and our Board of Directors; and
∙ provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements
Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable, not absolute, assurance that the objectives of the control system are met and may not prevent or detect misstatements. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process, and it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Further, over time control may become inadequate because of changes in conditions or the degree of compliance with the policies or procedures may deteriorate.
Our management assessed the effectiveness of our internal control over financial reporting as of February 28, 2019. In making its assessment, management used the criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). Based on its assessment, management has concluded that we had certain control deficiencies described below that constituted material weaknesses in our internal controls over financial reporting. As a result, our internal controls over financial reporting was not effective as of February 28, 2019.
A "material weakness" is defined under SEC rules as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis by the company's internal controls. As a result of management's review of the investigation issues and results, and other internal reviews and evaluations that were completed after the end of the quarter ending February 28, 2019, related to the preparation of management's report on internal controls over financial reporting required for this quarterly report on Form 10-Q, management concluded that we had material weaknesses in our control environment and financial reporting process consisting of the following:
1) lack of a functioning audit committee due to a lack of a majority of independent members and a lack of a majority of outside directors on our board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures; and
2) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements.
We do not believe the material weaknesses described above caused any meaningful or significant misreporting of our financial condition and results of operations for the period ended February 28, 2019. However, management believes that the lack of a functioning audit committee and the lack of a majority of outside directors on our board of directors results in ineffective oversight in the establishment and monitoring of required internal controls and procedures, which could result in a material misstatement in our financial statements in future periods.
Management Plan to Remediate Material Weaknesses
Management is pursuing the implementation of corrective measures to address the material weaknesses described below. In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we have initiated, or plan to initiate, the following series of measures:
We plan to appoint one or more outside directors to our board of directors who shall be appointed to an audit committee resulting in a fully functioning audit committee who will undertake the oversight in the establishment and monitoring of required internal controls and procedures such as reviewing and approving estimates and assumptions made by management when funds are available to us. Additionally, we will create written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements
We believe the remediation measures described above will remediate the material weaknesses we have identified and strengthen our internal control over financial reporting. We are committed to continuing to improve our internal control processes and will continue to diligently and vigorously review our financial reporting controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, we may determine to take additional measures to address control deficiencies or determine to modify, or in appropriate circumstances not to complete, certain of the remediation measures described above.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
In May 2013, COSO released an updated version of its Internal Control - Integrated Framework ("2013 Framework"). Initially issued in 1992, the original framework ("1992 Framework") provided guidance to organizations to design, implement and evaluate the effectiveness of internal control concepts and simplify their use and application. The 2013 Framework is intended to improve upon systems of internal control over external financial reporting by formalizing the principles embedded in the 1992 Framework, incorporating business and operating environment changes and increasing the framework’s ease of use and application. The 1992 Framework remained available until December 15, 2014, after which it was superseded by the 2013 Framework. As of February 28, 2019, the Company has transitioned to the 2013 Framework. The Company did not experience significant changes to its internal control over financial reporting as a result from the transition to the 2013 Framework.
This report does not include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only the management's report in this report.
PART II. OTHER INFORMATION
Item 1 - Legal Proceedings
From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.
We are currently a party to a lawsuit due to Ameritek Ventures' default of payments regarding the Company's warehouse located in Roanoke, Virginia. To date, there has been no resolution and/or settlement regarding this lawsuit. There are no other lawsuits or litigation to the knowledge of management nor is any litigation threatened against us, which may materially affect us.
Item 1A - Risk Factors
See Risk Factors set forth in Part I, Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended May 31, 2018 and the discussion in Item 1, above, under "Liquidity and Capital Resources."
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds
On March 26, 2019, the Company sold 1,000,000 shares of its Series C Voting Preferred Stock to Chaka Renee Mann, in exchange for $4,000. These newly issued shares will not be registered under the Securities Act of 1933, as amended (the "Act") and are to be issued in the reliance upon the exemption from registration provided by section 4(2) of the Act, Regulation 506, on the basis that the transaction does not involve a public offering.
Item 3 - Defaults Upon Senior Securities
None.
Item 4 - Submission of Matters to a Vote of Security Holders
None.
Item 5 - Other Information
None.
Item 6 - Exhibits
Incorporated by reference | |||||||
Exhibit | Exhibit Description | Filed herewith | Form | Period Ending | Exhibit | Filing Date | |
3.1 | Articles of Incorporation, as currently in effect | S-1 | 3.1 | 09/19/2011 | |||
3.2 | Bylaws, as currently in effect | S-1 | 3.2 | 09/19/2011 | |||
3.3 | Certificate of Designation, as currently in effect | 8-K | Mar. 25, 2019 | 3.3 | 03/27/2019 | ||
10.1 | Promissory Note between Ameritek Ventures and Dan Berger dated May 23, 2011 | S-1 | Aug. 31, 2011 | 10.1 | 11/08/2011 | ||
10.2 | Addendum to Promissory Note for Callable and Convertible Preferred Shares Secured by Ownership Rights in Tooling Mold dated April 13, 2012 | S-1 | Feb. 29, 2012 | 10.2 | 04/26/2012 | ||
10.3 | Asset Purchase Agreement | 8-K | Aug. 30, 2017 | 10.3 | 09/06/2017 | ||
31.1 | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||||
31.2 | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002. | X |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Ameritek Ventures Registrant |
||||
Date: May 14, 2019 | /s/ Clinton L. Stokes III | |||
Name: Clinton L. Stokes III | ||||
Title: Chief Executive Officer Principal Executive Officer
| ||||
Date: May 14, 2019 | /s/ Kenneth P. Mayeaux | |||
Name: Kenneth P. Mayeaux | ||||
Title: Chief Accounting Officer Principal Accounting Officer
| ||||
Pursuant to the requirements of the Securities Exchange Act of 1934, the following persons on behalf of the Registrant and in the capacities and on the dates indicated have signed this report below.
Signature | Title | Date | ||
/s/ Clinton L. Stokes III (Clinton L. Stokes III) |
Chief Executive Officer Principal Executive Officer |
May 14, 2019 | ||
/s/ Kenneth P. Mayeaux (Kenneth P. Mayeaux) |
Corporate Secretary and Chief Accounting Officer |
May 14, 2019 |